Thailand Blood Gas Analyzer and Cardiac Biomarker Market Outlook to 2025 - Thailand's Growing number of Heart Disease patients with Improving Healthcare Facilities will drive the Industry Growth in long term: Ken Research
GURUGRAM, India, Aug. 16, 2021 /PRNewswire/ --
- Launch of Smart Health ID (patient administration cloud service) during 2018–20 under Thailand 4.0 increased digital penetration among manufacturers & distributors.
- Access to patients' data to manage future demand of healthcare services and medical devices under Thailand 4.0.
- Expenditure on elderly population welfare in Thailand is anticipated to reach USD 148.5 Mn by 2021 with a double digit CAGR of 10.5% during 2016-2021.
- Hospital groups such as Bangkok, Bumrungrad, Kasemred have planned to open more hospital units to cater to increasing hospital demand for specialized areas such as Cardiovascular.
Road Map of Healthcare Industry under Thailand 4.0: Thailand Ministry of Public Health created a roadmap in making Thailand, the medical hub of ASEAN by 2025. The focus area for the first five years of the implementation (2017-2021) is majorly to promote health tourism and effective production of generic drugs. However, the focus will primarily shift to the usage of standardized medical robots & automated diagnostic devices especially to treat heart related diseases and targeted therapies.
Increasing Ageing Population: Demand for healthcare services is expected to grow as older population in Thailand is expected to increase from ~20% in 2019 to ~36% by 2050. Ageing population boom puts pressure on government to plan for facilitating the change by improving medical facilities in the hospitals. Treatment & care for chronic diseases will be among the primary focus for maintaining the health of elder citizens in the country.
Growth in Hospital Industry: Private Hospital industry is anticipated to grow at 10%-13% growth rate during 2020-2022, wherein large hospital groups with a large network will have advantages in both cost & personnel. Number of Hospitals on the other hand is anticipated to cross 1500 by 2022. Higher number of hospitals with increased personnel would ensure more number of healthcare tests to be conducted in the country.
Analysts at Ken Research in their latest publication "Thailand Blood Gas Analyzer and Cardiac Biomarker Market Outlook to 2025 – Blood Gas Analyzer: By Device Type (Medium to High Workload and Single Test Analyzer), By Product (Device and Reagent), By Region", by Ken Research suggested that the Blood Gas and Cardiac Biomarker Market in Thailand is expected to grow in the near future due to new hospitals opening in the country, expansion of existing hospitals, Rising Ageing Population, Per Capita Health Expenditure, booming Medical Tourism industry, and increasing Government spending over the years. The Blood Gas Analyzer market is expected to register a positive five year CAGR of 6.6% and Cardiac Biomarker to register a CAGR of 5.9% in terms of number of devices installed respectively during the forecast period 2020P-2025F.
Key Segments Covered:-
- Blood Gas Analyzer Market:
- By Type of Device (Number of Devices Installed)
- Medium to High Workload Device
- Single Test Analyzer Device
- By Type of Product (Revenue)
- Reagents
- Device
- By Region (Number of Devices Installed)
- Bangkok
- Central Region
- Northern Region
- North Eastern Region
- Southern Region
- Cardiac Biomarker Analyzer Market:-
- By Type of Product (Number of Devices Installed)
- Reagent
- Device
- By Type of Device (Number of Devices Installed)
- Semi-Automated Small Portable System
- Fully-Automated High End System
- By Type of Cardiac Biomarker (Revenue)
- Troponin
- CKMB
- NTproBNP
- D-Dimer
- Others
Companies Covered:-
- Major Manufacturing Brands:-
- Nova Biomedical
- Radiometer
- Techno Medica
- Roche Diagnostics
- Abbott
- Siemens
- Wondfo
- Osang Healthcare
- i-Sens
- Opti Medical
- Werfen
- Biomerieux
- Sysmex
- LSI Medience
- Quidel
- GP Getein
- Distributors:-
- MP Group
- NHealth
- Connect Diagnostics
- AEC Healthcare
- SE Supply Group
- Transmedic
- PCN Healthcare
- Meditop
- MSS
- Key Target Audience:-
- Blood Gas Analyzer Manufacturers, Importers and Distributors
- Cardiac Biomarker Manufacturers, Importers and Distributors
- Government and Regulatory Bodies
- Heart Hospitals & Research Institutions
- Medical Device Consultant Firms
- Industry Associations
- Time Period Captured in the Report:-
- Historical Period: 2014-2020
- Forecast Period: 2021-2025
Key Topics Covered in the Report:-
- Overview of Thailand Blood Gas and Cardiac Biomarker Analyzer Market
- Thailand Blood Gas and Cardiac Biomarker Analyzer Market Value Chain Analysis
- Thailand Blood Gas Analyzers Market Size
- Thailand Cardiac Biomarkers Market Size
- Thailand Blood Gas and Cardiac Biomarker Analyzer Market Ecosystem
- Thailand Blood Gas and Cardiac Biomarker Analyzer Market Segmentation
- Government Role and Regulation in Thailand Blood Gas and Cardiac Biomarker Analyzer Market
- Trends & Developments and Issues & Challenges in Thailand Blood Gas and Cardiac Biomarker Analyzer Market
- Competitive Landscape in Thailand Blood Gas and Cardiac Biomarker Analyzer Market
- Strength and Weakness of Major Players
- End User Perception
- Industry SWOT Analysis
- Future Market Size and Segmentations, 2020P-2025F
- Analysts' Recommendations
- Thailand Healthcare Industry
- Thailand Blood Gas Analyzer Industry
- Thailand Blood Gas Analyzer Devices
- Thailand Health Insurance System
- Thailand Blood Gas Analyzer Manufacturers
- Thailand Blood Gas Analyzer Distributors
- Thailand Cardiac Biomarker Manufacturers
- Thailand Cardiac Biomarker Industry
- Thailand IVD Market
- Thailand Cardiac Biomarker Regulations
- Thailand Blood Gas Analyzer Regulations
- Challenges in Thailand Cardiac Biomarker Market
- Challenges in Thailand Blood Gas Analyzer Market
- Point of Care Testing Device Industry
- Blood Gas Analyzers in Thailand
- Cardiac Biomarkers in Thailand
- Cardiac Biomarker Reagents in Thailand
- Cardiac Biomarker Reagent Revenue share Thailand
- Thailand Cardiac Biomarker Market Trends
- Thailand Cardiac Biomarker Import Procedure
- Thailand Blood Gas Analyzer Import Procedure
- Thailand Cardiac Biomarker Competitors
- Growth in Thailand Blood Gas Analyzer Market
- Thailand Single Test Blood Gas Analyzers
- Thailand Medium to High Workload Blood Gas Analyzers
- Thailand Semi Automated Cardiac Biomarkers
- Thailand Fully Automated Cardiac Biomarkers
- Number of Cardiac Biomarkers in Thailand
- Cardiac Biomarkers Devices in Bangkok
- Blood Gas Analyzers Devices in Bangkok
- Nova Biomedical Blood Gas Installed Thailand
- Edan Blood Gas Device Thailand
- NHealth Distributor Cardiac Biomarker Thailand
- Opti Medical Thailand Market Share
- LSI Medience Thailand Market Share
- Connect Diagnostics Cardiac Biomarker Distributor
- Connect Diagnostics Blood Gas Analyzer Distributor
- Thailand Troponin Market Share
- Thailand CKMB Market Share
- Thailand NTproBNP Market Share
- Thailand Cardiac Biomarkers Market Size
- Thailand Major Heart Hospitals
- Thailand Blood Gas Analyzer Future Growth
- Thailand Cardiac Biomarker Future Growth
For More Information on the research report, refer to below link:-
Thailand Blood Gas Analyzer and Cardiac Biomarker Market
Related Reports:-
Europe POCT Devices Market has grown registering a robust CAGR of close to 8% during the review period. Currently, the market is in growth stage with high potential of future expansion in both developed and developing countries of the region. Various factors supporting growth include high incidence of chronic diseases, rising health awareness, medical advancement in POCT sector, advancement in medical knowledge and R&D work, unease associated with laboratory testing methods and new companies venturing the market. Increase in urban population especially in the metro-cities which has been the largest end-user segment of the market and higher spending on R&D activities by the companies has led to the rise in number of point of care testing devices & customer interest. A substantial increase in awareness amongst population in cities & smaller towns has provided major thrust to this market. In parallel, growth & popularity of pregnancy & blood glucose POCT and advancement in technologies have given rise to new and improved devices. Advent of deadly infectious and cardiac diseases has led people to use these devices for quick detection. However, the market has been flooded with "fake" products, found all throughout the value chain.
India POCT market is at the growing stage. India POCT market in terms of revenue has increased at a positive CAGR during the period FY'2013-FY'2018. This growth was supported by advancement in medical knowledge and R&D along with increase in the prevalence of chronic diseases amongst the Indian population in the recent years. The customers in the market are becoming more aware of their health with time which has further boosted the demand for POCT devices in the country. There has been intense competition between the players in the India POCT market as more number of MNC's are setting up their units in India owing to the allowance of 100% FDI in the country. The domestic production of POCT devices has been relatively low as compared to other countries. The POCT devices have led a faster pace for treatment coupled with a reduction in the overall health checkup expenditure.
India blood gas and cardiac biomarker POC analyzer market grew at a double digit growth rate over the review period FY'2014-FY'2019. The market growth was supported by increase in public healthcare expenditure, growth in healthcare infrastructure in the country and rise in elderly population. The markets were observed to be in growth stage and will continue to remain so in the coming years. The demand for low cost devices and cheap cost per test alongwith change in decision making authority from doctors to hospital administration has significantly affected the growth in the market and has changed the procurement landscape in the industry.
Brazil Diagnostic Labs market in terms of revenue increased at a single-digit CAGR during the review period 2013-2019P. The market has witnessed significant growth owing to the presence of many independent laboratories. The intensity of competition among independent labs and clinical chains, increasing healthcare expenditure, improving healthcare infrastructure, rising elderly population and insurance penetration will improve the revenues from Diagnostic Labs in the country. The growing demand for routine tests and cost per test are the parameters that will affect the growth in the revenues of the Diagnostic Labs market.
In terms of revenue, the Australian diagnostic imaging market has registered a constant growth with positive CAGR in the last five years (FY'2012- FY'2018E). The diagnostic imaging market has witnessed an overall rise in bulk-billing rates in 2017. Key initiatives in the last 5 years included increasing the number of MBS-eligible MRI machines and improved "appropriate requesting" by health professionals to promote more efficient and effective use of diagnostic imaging services. There has been an overall improvement in patient access to MRI services but the "appropriate requesting" initiative was not substantively implemented.
Follow Our Social Media Pages:
Facebook: https://www.facebook.com/kenresearch
Twitter: https://twitter.com/KenResearch
LinkedIn: https://www.linkedin.com/company/ken-research/
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249
Logo: https://mma.prnewswire.com/media/661352/Ken_Research_Logo.jpg
Share this article